| DRD2 |
DRD2: D(2) dopamine receptor |
PIK4CB |
PIK4CB, RP11-126K1.4-003, hCG_1811976: Phosphatidylinositol 4-kinase, catalytic, |
1.305 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
1.305 |
Evidence |
|
| FASN |
FASN, FAS: Fatty acid synthase |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
1.305 |
Evidence |
|
| F8 |
F8, F8C: Coagulation factor VIII precursor |
SLC7A3 |
SLC7A3, ATRC3, CAT3: Cationic amino acid transporter 3 |
1.305 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
C9orf88 |
IPI00647286 |
1.305 |
Evidence |
|
| CSF1 |
CSF1: Macrophage colony-stimulating factor 1 precursor |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
1.305 |
Evidence |
|
| CASP3 |
CASP3, CPP32: Caspase-3 precursor |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
1.305 |
Evidence |
|
| TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
F5 |
F5: Coagulation factor V precursor |
1.305 |
Evidence |
|
| TOP2B |
IPI00217709 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
1.305 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SREBF2 |
IPI00478350 |
1.305 |
Evidence |
|
| BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
RNF20 |
|
1.305 |
Evidence |
|
| GART |
GART, PGFT, PRGS: Trifunctional purine biosynthetic protein adenosine-3 [Include |
DSG2 |
DSG2: Desmoglein-2 precursor |
1.305 |
Evidence |
|
| SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
1.305 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
CDC42 |
IPI00016786 |
1.305 |
Evidence |
|
| RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
1.305 |
Evidence |
|
| IL4 |
IL4: Interleukin-4 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
1.305 |
Evidence |
|
| RAD50 |
RAD50: DNA repair protein RAD50 |
DSG2 |
DSG2: Desmoglein-2 precursor |
1.305 |
Evidence |
|
| HIST1H1C |
HIST1H1C, H1F2: Histone H1.2 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
1.305 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
RAD50 |
RAD50: DNA repair protein RAD50 |
1.305 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
1.305 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
APP |
APP, A4, AD1: Amyloid beta A4 protein precursor |
1.305 |
Evidence |
|
| ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
PILRA |
PILRA: Paired immunoglobulin-like type 2 receptor alpha precursor |
1.305 |
Evidence |
|
| XRCC6 |
XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 |
CHTF18 |
RUVBL, CHTF18: Protein CTF18 homolog. |
1.305 |
Evidence |
|
| KRT6E |
KRT6C, KRT6E: Keratin, type II cytoskeletal 6C |
DSG2 |
DSG2: Desmoglein-2 precursor |
1.305 |
Evidence |
|
| PDE5A |
PDE5A, PDE5: cGMP-specific 3',5'-cyclic phosphodiesterase |
CREBBP |
CREBBP, CBP: CREB-binding protein |
1.305 |
Evidence |
|
- 
- 
-